Table VI.
Group | Fatty change regions (%/200 μm2 liver parenchyma) | Atherosclerotic plaques (%/1 mm aorta surface) | |
---|---|---|---|
| |||
Abdominal aorta | Thoracic aorta | ||
Sham | 0.86±0.39 | 0.64±0.56 | 0.43±0.17 |
Control | 93.94±2.88a | 8.12±1.89a | 8.32±2.33a |
SIMVA | 94.61±2.73a | 1.55±0.48b,c | 1.02±0.19a,c |
Polycan 31.25 | 84.76±4.93a,c | 4.54±1.20a,c | 2.83±0.87a,c |
Polycan 62.5 | 77.60±8.62a,c | 2.70±1.13a,c | 2.11±0.69a,c |
Polycan 125 | 76.61±8.74a,c | 2.40±1.36b,c | 1.60±0.93a,c |
Results are expressed as the mean ± standard deviation (n=5).
P<0.01 and
P<0.05, vs. sham (MW test);
P<0.01, vs. vehicle control (MW test).
SIMVA, simvastatin; MW, Mann-Whitney-Wilcoxon.